2018 Annual Meeting | C129 - Cerebrovascular Disease II: Update on Guidance-Based Diagnosis and Management of Hemorrhagic Stroke

Date Tuesday 04/24/18

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Philip B. Gorelick, MD, MPH, FAAN

Topic(s)

Learning Objectives Participants should be able to properly diagnose, manage, and prevent subarachnoid hemorrhage and intraparenchymal according to major guideline statements. New study data that may influence every day neurologic practice also will be discussed.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Tracks Advanced Practice Provider, Neurohospitalist

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic

Event Timeline
03:30 PM - 04:15 PM	Speaker	Diagnosis and Management of Subarachnoid Hemorrhage Venkatesh Aiyagari, MD
04:15 PM - 04:30 PM	Q&A	Questions and Answers
04:30 PM - 05:15 PM	Speaker	Diagnosis and Management of Intraparenchymal Hemorrhage Andrew M. Naidech, MD, FAAN
05:15 PM - 05:30 PM	Q&A	Questions and Answers

Faculty Disclosures
Philip B. Gorelick, MD, MPH, FAAN	Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Thorek Memorial Hospital. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Thorek Memorial Hospital.
Venkatesh Aiyagari, MD	Dr. Aiyagari has received publishing royalties from a publication relating to health care.
Andrew M. Naidech, MD, FAAN	No disclosure on file